2700062C07Rik Activators
2700062C07Rik Activators encompass a diverse array of chemical compoundsthat harness various signaling pathways to amplify the functional activity of 2700062C07Rik. Forskolin, by elevating intracellular cAMP levels, indirectly enhances 2700062C07Rik's function through PKA activation, which could phosphorylate the protein or its regulatory factors. Isoproterenol and Dibutyryl cAMP (db-cAMP) also increase cAMP and activate PKA, suggesting a common mechanism where 2700062C07Rik might be regulated by PKA-mediated phosphorylation. In a similar vein, Sildenafil, known for inhibiting PDE5, would raise cAMP and cGMP levels, potentially engaging PKG or PKA pathways that may govern 2700062C07Rik's activity. On another front, Ionomycin acts as a calcium ionophore, and Spermine modulates NMDA receptor activity, both could elevate intracellular calcium and activate calcium-dependent kinases such as CaMK, which may phosphorylate and activate 2700062C07Rik. Phorbol 12-myristate 13-acetate (PMA) specifically activates PKC, which could directly modify 2700062C07Rik activity if PKC-mediated phosphorylation is part of its regulatory mechanism.
Further refining the regulation of 2700062C07Rik, LY294002 and SB203580 modulate the PI3K/Akt and p38 MAPK pathways, respectively, which could relieve 2700062C07Rik from negative feedback or inhibitory phosphorylation, thereby enhancing its activity. Curcumin, with its ability to inhibit NF-κB, may also lift negative regulation from 2700062C07Rik, if NF-κB is a suppressor in its signaling cascade. Epigallocatechin gallate (EGCG), through kinase inhibition, might remove inhibitory kinases that dampen 2700062C07Rik's activity, leading to its functional activation. Lastly, Retinoic acid, acting through nuclear receptors, might upregulate proteins that positively influence 2700062C07Rik's functional state, taking a genomic route to enhance its activity. Collectively, these activators orchestrate a symphony of biochemical events that converge on the amplification of 2700062C07Rik's activity, each through a unique but interrelated mechanism, emphasizing the complexity and integration of cellular signaling pathways.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, potentially activating calcium-dependent kinases such as CaMK, which could then activate 2700062C07Rik by phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could phosphorylate and enhance the activity of 2700062C07Rik or associated substrates if PKC is part of the protein's signaling cascade. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a known inhibitor of several kinases, which might relieve negative regulatory kinases from 2700062C07Rik, thus enhancing its activity through disinhibition. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine can modulate NMDA receptor activity and indirectly activate signaling cascades involving CaMK or PKC, which could lead to the activation of 2700062C07Rik if it is modulated by calcium signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could indirectly enhance the activity of 2700062C07Rik by shifting the cellular signaling balance if 2700062C07Rik is regulated by PI3K/Akt pathway components. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could enhance the activity of 2700062C07Rik by suppressing inhibitory phosphorylation if 2700062C07Rik is part of a pathway negatively regulated by p38 MAPK. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has multiple targets within cell signaling pathways, including inhibition of NF-κB. This could lead to activation of 2700062C07Rik if NF-κB serves as a negative regulator of the protein or its pathway. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through retinoic acid receptors, which could enhance the activity of 2700062C07Rik by promoting transcription of genes encoding proteins that positively regulate 2700062C07Rik. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
db-cAMP is a cAMP analog that activates PKA. PKA could then activate 2700062C07Rik by phosphorylation if the protein is modulated by cAMP/PKA signaling. | ||||||